Prevention of betel quid chewers' oral cancer in the asian-pacific area

Asian Pacific Journal of Cancer Prevention

Volumn 2, Issue 4, 2001, Pages 263-269

  Chiba, Itsuo ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Betel quid; Genetic changes; Oral cancer; Premalignancy; Prevention

Indexed keywords

EID: 0037936238     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (64)

1. Boyle P, Macfarlane GJ, Maisonneuve P, et al (1990). Epidemiology of mouth cancer in 1989: a review. J R Soc Med, 83, 724-30.
2. Chang SE, Bhatia P, Johnson NW, et al (1991). Ras mutations in United Kingdom examples of oral malignancies are infrequent. Int J Cancer, 48, 409-12.
3. Chiba I, Muthumala M, Yamazaki Y, et al (1998). Characteristics of mutations in the p53 gene of oral squamous-cell carcinomas associated with betel-quid chewing in Sri Lanka. Int J Cancer, 77, 839-42.
4. Dave BJ, Trivedi AH, Adhvaryu SG (1992). Role of areca nut consumption in the cause of oral cancers. A cytogenetic assessment. Cancer, 70, 1017-23.
5. Field JK, Spandidos DA (1987). Expression of oncogenes in human tumors with special reference to the head and neck region. J Oral Pathol, 16, 97-107.
6. Gupta PC (1991). Betel quid and oral cancer: prospects for prevention. IARC Sci Publ, 466-70.
7. Gupta PC (1996). Survey of sociodemographic characteristics of tobacco use among 99,598 individuals in Bombay, India using handheld computers. Tob Control, 5, 114-20.
8. Gupta PC, Bhonsle RB, Murti PR, et al (1989). An epidemiologic assessment of cancer risk in oral precancerous lesions in India with special reference to nodular leukoplakia. Cancer, 63, 2247-52.
9. Gupta PC, Mehta FS, Pindborg JJ, et al (1986). Intervention study for primary prevention of oral cancer among 36 000 Indian tobacco users. Lancet, 1, 1235-9.
10. Gupta PC, Mehta FS, Pindborg JJ, et al (1992). Primary prevention trial of oral cancer in india: a 10-year follow-up study. J Oral Pathol Med, 21, 433-9.
11. Gupta PC, Mehta FS, Pindborg JJ, et al (1990). A primary prevention study of oral cancer among Indian villagers. Eightyear follow-up results. IARC Sci Publ, 149-56.
12. Gupta PC, Mehta HC (2000). Cohort study of all-cause mortality among tobacco users in Mumbai, India. Bull World Health Organ, 78, 877-83.
13. Gupta PC, Murti PR, Bhonsle RB (1996). Epidemiology of cancer by tobacco products and the significance of TSNA. Crit Rev Toxicol, 26, 183-98.
14. Gupta PC, Murti PR, Bhonsle RB, Mehta FS, Pindborg JJ (1995). Effect of cessation of tobacco use on the incidence of oral mucosal lesions in a 10-yr follow-up study of 12,212 users. Oral Dis, 1, 54-8.
15. Gupta PC, Pindborg JJ, Mehta FS (1982). Comparison of carcinogenicity of betel quid with and without tobacco: an epidemiological review. Ecol Dis, 1, 213-9.
16. Hirayama T (1966) An epidemiological study of oral and pharyngeal cancer in Central and South-East Asia. Bull Wld Hlth Org, 34, 41-69.
17. Hoffmann D, Brunnemann KD, Prokopczyk B, Djordjevic MV (1994). Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans. J. Toxicol. Env. Health, 41, 1-52.
18. IARC Monograph I, Evaluation of the carcinogenic risk of chemicals to human: Tobacco habits other than smoking; betelquid and areca nut chewing; and some related nitrosamines. Vol. 37, pp. 141-200, International Agency for Research on Cancer, Lyon, France (1985).
19. Jang SJ, Chiba I, Hirai A, Hong WK, Mao L (2001). Multiple oral squamous epithelial lesions: are they genetically related? Oncogene, 20, 2235-42.
20. Jayant K, Balakrishnan V, Sanghvi LD, Jussawalla DJ (1977). Quantification of the role of smoking and chewing tobacco in oral, pharyngeal, and oesophageal cancers. Brit J Cancer, 35, 232-5.
21. Kashiwazaki H, Tonoki H, Tada M, et al (1997). High frequency of p53 mutations in human oral epithelial dysplasia and primary squamous cell carcinoma detected by yeast functional assay. Oncogene, 15, 2667-74.
22. Kaur J, Srivastava A, Ralhan R (1994). Overexpression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India. Int J Cancer, 58, 340-5.
23. Kiyohara C (2000) Genetic polymorphism of enzymes involved in xenobiotic metabolism and the risk of colorectal cancer. J Epidemiol, 10, 349-60.
24. Kuo MY, Jeng JH, Chiang CP, Hahn LJ (1994). Mutations of Kiras oncogene codon 12 in betel quid chewing-related human oral squamous cell carcinoma in Taiwan. J Oral Pathol Med, 23, 70-4.
25. Kuttan NAA, Rosin MP, Ambika K, et al (1995). High prevalence of expression of p53 oncoprotein in oral carcinomas from India associated with betel and tobacco chewing. Eur J Cancer, 31B, 169-173.
26. Maher R, Aga P, Johnson NW, Sankaranarayanan R, Warnakulasuriya S (1997). Evaluation of multiple micronutrient supplementation in the management of oral submucous fibrosis in Karachi, Pakistan. Nutr Cancer, 27, 41-7.
27. Matsuda H, Konishi N, Hiasa Y, et al (1996). Alterations of p16/ CDKN2, p53 and ras genes in oral squamous cell carcinomas and premalignant lesions. J Oral Pathol Med, 25, 232-8.
28. Matthias C, Bockmuhl U, Jahnke V, et al (1998). Polymorphism in cytochrome P450 CYP2D6, CYP1A1, CYP2E1 and glutathione S-transferase, GSTM1, GSTM3, GSTT1 and susceptibility to tobacco-related cancers: studies in upper aerodigestive tract cancers. Pharmacogenetics, 8, 91-100.
29. Mehta FS, Gupta PC, Bhonsle RB, et al (1986). Detection of oral cancer using basic health workers in an area of high oral cancer incidence in India. Cancer Detect Prev, 9, 219-25.
30. Mehta FS, Gupta PC, Pindborg JJ, (1981). Chewing and smoking habits in relation to precancer and oral cancer. J Cancer Res Clin Oncol, 99, 35-9.
31. Mehta FS, Hamner JEI, (1993). Tobacco-related oral mucosal lesions and conditions in India, Basic Dental Research Unit, Tata Institute of Fundamental Research, Bombay, India.
32. Murti PR, Bhonsle RB, Gupta PC, et al (1995). Etiology of oral submucous fibrosis with special reference to the role of areca nut chewing. J Oral Pathol Med, 24, 145-52.
33. Murti PR, Bhonsle RB, Pindborg JJ, et al (1985). Malignant transformation rate in oral submucous fibrosis over a 17-year period. Community Dent Oral Epidemiol, 13, 340-1.
34. Murti PR, Daftary DK, Bhonsle RB, et al (1986). Malignant potential of oral lichen planus: observations in 722 patients from India. J Oral Pathol, 15, 71-7.
35. Murti PR, Warnakulasuriya KA, Johnson NW, et al (1998). p53 expression in oral precancer as a marker for malignant potential. J Oral Pathol Med, 27, 191-6.
36. Nair MK, Sankaranarayanan R, Padmanabhan TK, Padmakumari G, (1988) .Clinical profile of 2007 oral cancers in Kerala, India. Annals of Dentistry, 47, 23-6.
37. Nair U, Bartsch H (2001). Metabolic polymorphisms as susceptibility markers for lung and oral cavity cancer. IARC Sci Publ, 154, 271-90.
38. Nair UJ, Friesen M, Richard I, et al (1990). Effect of lime composition on the formation of reactive oxygen species from areca nut extract in vitro. Carcinogenesis, 11, 2145-8.
39. Nair UJ, Nair J, Mathew B, Bartsch H (1999). Glutathione Stransferase M1 and T1 null genotypes as risk factors for oral leukoplakia in ethnic Indian betel quid/tobacco chewers. Carcinogenesis, 20, 743-8.
40. Pillai R, Reddiar KS, Balaram P (1991). Oncogene expression and oral cancer. J Surg Oncol, 47, 102-8.
41. Pindborg JJ (1980). Oral Cancer and Precancer, Bristor, John Wright & Sons.
42. Pindborg JJ, Murti PR, Bhonsle RB, et al (1984). Oral submucous fibrosis as a precancerous condition. Scand J Dent Res, 92, 224-9.
43. Ranasinghe AW, Warnakulassuriya KAAS, Johnson N W (1993). Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing. Eur J Cancer, 29B, 147-150,.
44. Randeniya B (1987). Cancer Incidence in Sri Lanka, Maharagama Cancer Institute.
45. Ratnapala N (1989). Rural poverty in Sri Lanka, Asoka Bataduwa Arachchi, Nugegoda, Sri Lanka.
46. Report on Consumer Finances and Socio Economic Survey 1996/ 97 (1999), Part 1, Central Bank of Sri Lanka, Colombo
47. Sakai E, Rikimaru K, Ueda M, et al (1992). The p53 tumorsuppressor gene and ras oncogene mutations in oral squamouscell carcinoma. Int J Cancer, 52, 867-872.
48. Sakata K, (1996). Alterations of tumor suppressor genes and the H-ras oncogene in oral squamous cell carcinoma. J Oral Pathol Med, 25, 302-7.
49. Sankaranarayanan R, Nair MK, Mathew B, et al (1992). Recent results of oral cancer research in Kerala, India. Head Neck J Sci Spec, 14, 107-12.
50. Saranath D, Chang SE, Bhoite LT, et al (1991) High frequency mutation in codons 12 and 61 of H-ras oncogene in chewing tobacco-related human oral carcinoma in India. Brit J Cancer, 63, 573-8.
51. Sinor PN, Gupta PC, Murti PR, et al (1990). A case-control study of oral submucous fibrosis with special reference to the etiologic role of areca nut. J Oral Pathol Med, 19, 94-8.
52. Slaughter DP, Southwick HW, (1953). "Field cancerization" in oral stratified squamous epithelium. Cancer, 6, 936-968.
53. Sri Lanka Socio-Economic Data (1998). Statistics Department, Central Bank of Sri Lanka.
54. Stich HF, Brunnemann KD, Mathew B, Sankaranaryanan R, Nair MK (1989). Chemopreventive trials with vitamin A and betacarotene: some unresolved issues. Prev Med, 18, 732-9.
55. Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Nair MK (1988). Response of oral leukoplakias to the administration of vitamin A. Cancer Lett, 40, 93-101.
56. Stich HF, Rosin MP, Hornby AP, et al (1988). Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A. Int J Cancer, 42, 195-9.
57. Sundqvist K, Liu Y, Erhardt P, et al (1991). Areca-nut toxicity in cultured human buccal epithelial cells. IARC Sci Publ, 105, 281-5.
58. Topcu Z, Chiba I, Ariyoshi N, et al (1997). Field cancerisation and polyclonal p53 mutation in the upper aero-digestive tract. Oncogene, 14, 163-9.
59. Warnakulasuriya KA, Chang SE, Johnson NW (1992). Point mutations in the Ha-ras oncogene are detectable in formalinfixed tissues of oral squamous cell carcinomas, but are infrequent in British cases. J Oral Pathol Med, 21, 225-9.
60. Wary KK, Sharan RN, (1991). Cytotoxic and cytostatic effects of arecoline and sodium nitrite on human cells in vitro. Int J Cancer, 47, 396-400.
61. Xu J, Gimenez-Conti IB, Cunningham JE, et al (1998). Alterations of p53, cyclin D1, Rb, and H-ras in human oral carcinomas related to tobacco use. Cancer, 83, 204-12.
62. Yeudall WA, Torrance LK, Elsegood KA, et al (1993). Ras gene point mutation is a rare event in premalignant tissues and malignant cells and tissues from oral mucosal lesions. Eur J Cancer Oral Oncol, 29B, 63-7.
63. Zain RB, Gupta PC, Warnakulasuriya S, et al (1997). Oral lesions associated with betel quid and tobacco chewing habits. Oral Dis, 3, 204-5.
64. Zain RB, Ikeda N, Gupta PC, et al (1999). Oral mucosal lesions associated with betel quid, areca nut and tobacco chewing habits: consensus from a workshop held in Kuala Lumpur, Malaysia, November 25-27, 1996. J Oral Pathol Med, 28, 1-4.